A retrospective review of the long-term outcomes of online adaptive radiation therapy and conventional radiation therapy for muscle invasive bladder cancer

by Janice Yeh, Mathias Bressel, Keen Hun Tai, Tomas Kron, Farshad Foroudi
Published 2021-09-01

Support for the use of objective comorbidity indices in the assessment of noncancer death risk in prostate cancer patients

by Sweet Ping Ng, Gillian Duchesne, Keen-Hun Tai, Farshad Foroudi, Gargi Kothari, Scott Williams
Published 2017-03-01

Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up

by Ciara Conduit, Thuan Tzen Koh, Michael S Hofman, Guy C Toner, Jeremy Goad, Nathan Lawrentschuk, Keen-Hun Tai, Jeremy H Lewin, Ben Tran
Published 2022-10-01

Risk Stratification after Biochemical Failure following Curative Treatment of Locally Advanced Prostate Cancer: Data from the TROG 96.01 Trial

by Allison Steigler, James W. Denham, David S. Lamb, Nigel A. Spry, David Joseph, John Matthews, Chris Atkinson, Sandra Turner, John North, David Christie, Keen-Hun Tai, Chris Wynne
Published 2012-01-01

TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol

by Jeremy Millar, Jarad Martin, Paul Keall, Shankar Siva, Peter Greer, David Christie, Jason Dowling, David Pryor, Peter Chong, Nicholas McLeod, Avi Raman, James Lynam, Joanne Smart, Declan G Murphy, Keen Hun Tai, Lois Holloway, Amy Hayden, Tee Lim, Tanya Holt, Mark Sidhom
Published 2019-08-01